Biocognon

Molecular recognition technology for better antibodies

A Nanobody discovery platform to transform the discovery and development of antibody-based therapeutics and diagnostics.

Biocognon’s Nanobody platform is based on novel yeast surface-expressed fluorogenic biosensors.